Ozempic (semaglutide) typically lowers A1C by 1.0 to 1.8 percentage points, depending on the dose and how high your A1C is when you start. At the standard 1.0 mg weekly dose, clinical trials consistently showed reductions of 1.5 to 1.8 percentage points over 30 to 56 weeks. That’s enough to bring many people from an A1C of 8% or higher down into the 7% range or below.
A1C Reduction by Dose
Ozempic is prescribed at three dose levels, and each one delivers a different degree of A1C lowering. The 1.0 mg weekly dose, which is the most commonly prescribed, reduced A1C by 1.5 to 1.8 percentage points across the SUSTAIN clinical trial program. The higher 2.0 mg dose, approved more recently, pushes that further. In the SUSTAIN FORTE trial, the 2.0 mg dose lowered A1C by 2.2 percentage points from baseline at 40 weeks, compared to 1.9 percentage points with the 1.0 mg dose.
Most people start at 0.25 mg for the first four weeks, then move to 0.5 mg, and eventually up to 1.0 mg or 2.0 mg. The starting doses are meant to help your body adjust and reduce side effects, not to deliver the full blood sugar benefit. The meaningful A1C reductions come once you reach a maintenance dose of 1.0 mg or higher.
How Quickly It Works
You won’t need to wait months to see movement in your blood sugar. Ozempic starts lowering blood glucose within days of the first injection, but since A1C reflects your average blood sugar over roughly three months, the number on your lab work takes longer to shift. In one 56-week clinical study, participants who started with an average A1C of 8% saw it drop to 7% by week 8, and down to 6.5% or below by week 16.
The full effect on A1C generally takes about 12 weeks of steady dosing at your maintenance dose. Since the first several weeks involve lower doses for tolerability, the realistic timeline from your first injection to peak A1C reduction is closer to four or five months.
How Ozempic Lowers Blood Sugar
Ozempic is a GLP-1 receptor agonist, which means it mimics a gut hormone your body naturally releases after eating. It works through two main channels. First, it signals your pancreas to release more insulin when your blood sugar is elevated after meals. Second, it lowers levels of glucagon, a hormone that tells your liver to release stored sugar into your bloodstream. By boosting insulin and suppressing glucagon at the same time, it brings post-meal blood sugar spikes down significantly.
Because this insulin release is tied to meals, Ozempic carries a low risk of causing dangerously low blood sugar (hypoglycemia) on its own. The drug also slows stomach emptying, which means food enters your bloodstream more gradually, smoothing out the blood sugar peaks that drive A1C up over time.
How Ozempic Compares to Other Medications
Adding a GLP-1 medication like Ozempic to metformin typically results in 1 to 2+ percentage points of additional A1C lowering. The American Diabetes Association’s 2025 treatment guidelines specifically note that semaglutide and tirzepatide (Mounjaro) produce some of the largest A1C reductions of any non-insulin medication.
In head-to-head comparisons, tirzepatide does edge out semaglutide. A large network meta-analysis covering more than 18,000 participants found that the highest dose of tirzepatide (15 mg) lowered A1C by about 2.0 percentage points versus placebo, while semaglutide 2.0 mg lowered it by about 1.6 percentage points. At higher doses, Mounjaro reduces A1C by roughly 2.0 to 2.5 percentage points compared to Ozempic’s 1.0 to 1.8 points. Both are considered among the most effective options available, and the ADA guidelines recommend GLP-1 medications over insulin for most adults with type 2 diabetes who don’t have insulin deficiency.
What Affects Your Individual Results
The percentage-point reductions from clinical trials are averages, and your personal results will depend on several factors. The biggest one is your starting A1C. People with higher baseline levels tend to see larger absolute drops. Someone starting at 9.5% may see a reduction of 2 points or more, while someone starting at 7.5% might see a drop closer to 1 point. This isn’t because the drug works less well at lower levels; there’s simply less room to improve.
Diet and exercise still matter. Ozempic is powerful, but it works alongside your other habits, not as a replacement for them. How well you tolerate the medication also plays a role. If nausea or other side effects slow your dose increases, it may take longer to reach the dose that delivers full A1C benefits. Consistency matters too: missing weekly injections will blunt the effect.
Your doctor will typically set a personalized A1C goal based on your age, how long you’ve had diabetes, your risk of low blood sugar, and any other health conditions. The ADA recommends that when someone’s A1C is 1.5 or more percentage points above their individual goal, a potent medication like semaglutide or combination therapy is appropriate to close that gap.